A Systematic Review of Anti-Rotavirus Serum IgA Antibody Titer as a Potential Correlate of Rotavirus Vaccine Efficacy

Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants

(2014) Anil Narang et al.   Human vaccines & immunotherapeutics

Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?

(2012) Manish M Patel et al.   LANCET INFECTIOUS DISEASES

Efficacy of the oral pentavalent rotavirus vaccine in Mali

(2012) Samba O. Sow et al.   VACCINE

Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam

(2012) Sunheang Shin et al.   VACCINE

Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial

(2012) Nigel A. Cunliffe et al.   VACCINE

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial

(2012) S.A. Madhi et al.   VACCINE

Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine

(2012) Robert F. Breiman et al.   VACCINE

Immunogenicity of the pentavalent rotavirus vaccine in African infants

(2012) George E. Armah et al.   VACCINE

Immunogenicity, reactogenicity and safety of a human rotavirus vaccine (RIX4414) in Korean infants: A randomized, double-blind, placebo-controlled, phase IV study

(2012) Jung Soo Kim et al.   Human Vaccines & Immunotherapeutics

Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life

(2011) Naohisa Kawamura et al.   VACCINE

Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006–2007

(2011) D.D. Anh et al.   VACCINE

Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants

(2011) T. Vesikari et al.   VACCINE

Immunogenicity of a live-attenuated human rotavirus RIX4414 vaccine with or without buffering agent

(2010) Angkool Kerdpanich et al.   Human vaccines & immunotherapeutics

Performance of rotavirus vaccines in developed and developing countries

(2010) Victoria Jiang et al.   Human vaccines & immunotherapeutics

Comparison of 2 Different Regimens for Reactogenicity, Safety, and Immunogenicity of the Live Attenuated Oral Rotavirus Vaccine RIX4414 Coadministered with Oral Polio Vaccine in South African Infants

(2010) A. D. Steele et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

(2010) K Zaman et al.   LANCET

Rotavirus: realising the potential of a promising vaccine

(2010) E Anthony S Nelson et al.   LANCET

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

(2010) George E Armah et al.   LANCET

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

(2010) Shabir A. Madhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sustained Efficacy of the Pentavalent Rotavirus Vaccine, RV5, up to 3.1 Years Following the Last Dose of Vaccine

(2010) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and safety of the human rotavirus vaccine Rotarix™ co-administered with routine infant vaccines following the vaccination schedules in Europe

(2010) Timo Vesikari et al.   VACCINE

A Dose‐Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double‐Blind, Placebo‐Controlled Trial

(2009) Nita Bhandari et al.   JOURNAL OF INFECTIOUS DISEASES

Mucosal Immunity after Vaccination with Monovalent and Trivalent Oral Poliovirus Vaccine in India

(2009) Nicholas C. Grassly et al.   JOURNAL OF INFECTIOUS DISEASES

Oral Rotavirus Vaccines: How Well Will They Work Where They Are Needed Most?

(2009) Manish Patel et al.   JOURNAL OF INFECTIOUS DISEASES

Experience of Pentavalent Human-bovine Reassortant Rotavirus Vaccine Among Healthy Infants in Taiwan

(2009) Chien-Chih Chang et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age

(2009) K. Zaman et al.   VACCINE

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

(2009) K.B. Phua et al.   VACCINE

Rotavirus vaccines: how they work or don't work

(2008) Richard L. Ward   EXPERT REVIEWS IN MOLECULAR MEDICINE

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

(2008) Alexandre C Linhares et al.   LANCET

Concomitant Use of the Oral Pentavalent Human-Bovine Reassortant Rotavirus Vaccine and Oral Poliovirus Vaccine

(2008) Max Ciarlet et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL